Medtronic Concerto
This article was originally published in The Gray Sheet
Executive Summary
Firm announces the first patient implants of its Concerto AT CRT-D device with atrial therapies Feb. 1. The prospective, non-randomized trial will include 425 patients indicated for cardiac resynchronization therapy and implantable cardioverter defibrillators at 50 sites in Europe, Japan and the U.S. Medtronic's Concerto CRT-D and its Virtuoso ICD will be the firm's first devices to incorporate Conexus telemetry for automatic, wireless transmission of implanted device data to the firm's CareLink internet-based monitoring system...